Clinical Guidelines for Drug-Related Peptic Ulcer, 2020 Revised Edition
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Joo, Moon Kyung | - |
dc.contributor.author | Park, Chan Hyuk | - |
dc.contributor.author | Kim, Joon Sung | - |
dc.contributor.author | Park, Jae Myung | - |
dc.contributor.author | Ahn, Ji Yong | - |
dc.contributor.author | Lee, Bong Eun | - |
dc.contributor.author | Lee, Jeong Hoon | - |
dc.contributor.author | Yang, Hyo-Joon | - |
dc.contributor.author | Cho, Yu Kyung | - |
dc.contributor.author | Bang, Chang Seok | - |
dc.contributor.author | Kim, Beom Jin | - |
dc.contributor.author | Jung, Hye-Kyung | - |
dc.contributor.author | Kim, Byung-Wook | - |
dc.contributor.author | Lee, Yong Chan | - |
dc.date.accessioned | 2021-12-08T19:42:08Z | - |
dc.date.available | 2021-12-08T19:42:08Z | - |
dc.date.created | 2021-08-30 | - |
dc.date.issued | 2020-11 | - |
dc.identifier.issn | 1976-2283 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/130398 | - |
dc.description.abstract | Korean guidelines for nonsteroidal anti-inflammatory drug (NSAID)-induced peptic ulcer were previously developed in 2009 with the collaboration of the Korean College of Helico-bacter and Upper Gastrointestinal Research and Korean Society of Gastroenterology. However, the previous guidelines were based mainly upon a review of the relevant literature and expert opinion. Therefore, the guidelines need to be revised. We organized a guideline Development Committee for drug-related peptic ulcer under the auspices of the Korean College of Helicobacter and Upper Gastrointestinal Research in 2017 and developed nine statements, including four for NSAIDs, three for aspirin and other antiplatelet agents, and two for anticoagulants through a de novo process founded on evidence-based medicine that included a literature search and a meta-analysis, A consensus was reached through the application of the modified Delphi method. The primary target of these guidelines is adult patients undergoing long-term treatment with NSAIDs, aspirin or other antiplatelet agents and anticoagulants. The revised guidelines reflect the expert consensus and is intended to assist clinicians in the management and prevention of drug-induced peptic ulcer and associated conditions. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | EDITORIAL OFFICE GUT & LIVER | - |
dc.subject | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | - |
dc.subject | PROTON PUMP INHIBITORS | - |
dc.subject | LOW-DOSE ASPIRIN | - |
dc.subject | HELICOBACTER-PYLORI INFECTION | - |
dc.subject | RHEUMATOID-ARTHRITIS PATIENTS | - |
dc.subject | LONG-TERM RISK | - |
dc.subject | DOUBLE-BLIND | - |
dc.subject | GASTRODUODENAL ULCERS | - |
dc.subject | GASTROINTESTINAL SAFETY | - |
dc.subject | CONTROLLED-TRIAL | - |
dc.title | Clinical Guidelines for Drug-Related Peptic Ulcer, 2020 Revised Edition | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Joo, Moon Kyung | - |
dc.identifier.doi | 10.5009/gnl20246 | - |
dc.identifier.scopusid | 2-s2.0-85096270818 | - |
dc.identifier.wosid | 000591659600005 | - |
dc.identifier.bibliographicCitation | GUT AND LIVER, v.14, no.6, pp.707 - 726 | - |
dc.relation.isPartOf | GUT AND LIVER | - |
dc.citation.title | GUT AND LIVER | - |
dc.citation.volume | 14 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 707 | - |
dc.citation.endPage | 726 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.identifier.kciid | ART002647047 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Gastroenterology & Hepatology | - |
dc.relation.journalWebOfScienceCategory | Gastroenterology & Hepatology | - |
dc.subject.keywordPlus | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | - |
dc.subject.keywordPlus | PROTON PUMP INHIBITORS | - |
dc.subject.keywordPlus | LOW-DOSE ASPIRIN | - |
dc.subject.keywordPlus | HELICOBACTER-PYLORI INFECTION | - |
dc.subject.keywordPlus | RHEUMATOID-ARTHRITIS PATIENTS | - |
dc.subject.keywordPlus | LONG-TERM RISK | - |
dc.subject.keywordPlus | DOUBLE-BLIND | - |
dc.subject.keywordPlus | GASTRODUODENAL ULCERS | - |
dc.subject.keywordPlus | GASTROINTESTINAL SAFETY | - |
dc.subject.keywordPlus | CONTROLLED-TRIAL | - |
dc.subject.keywordAuthor | Peptic ulcer | - |
dc.subject.keywordAuthor | Non-steroidal anti-inflammatory agents | - |
dc.subject.keywordAuthor | Antiplatelet agent | - |
dc.subject.keywordAuthor | Anticoagulants | - |
dc.subject.keywordAuthor | Guideline | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.